Presenter-only talk track
CEO live presentation
Open this route in a separate window. Speaker notes never enter the audience deck or its print output.
Slide 1 The next right step for everyday parenting moments.
Assumption · Internal financing hypothesis pending the monthly cash ledger.
- Say
- We are building bounded decision support for recurring everyday moments—not an AI parenting expert and not a clinical service.
- Proof
- The frozen v1 scope and 18-month validation plan make the first investment question explicit.
- Do not hide
- €400k and the 18-month runway remain provisional until the monthly cash ledger reconciles.
- Likely follow-up
- Expect investors to ask which exact protocol enters the first programme and who owns it.
Slide 2 When a hard moment happens, parents need an appropriate next step now.
Assumption · Problem hypothesis; evidence pending.
- Say
- The difficult job is choosing what to try during a transition, boundary, or routine conflict—not finding another article.
- Proof
- The 100-parent programme is structured to measure this job directly.
- Do not hide
- We do not yet have denominated parent research proving frequency, urgency, or willingness to pay.
- Likely follow-up
- Expect a request for interview method, recruitment criteria, and evidence that the job repeats.
Slide 3 Content, a chatbot, and an appointment each solve only part of the job.
Assumption · Category framing; no superiority asserted.
- Say
- We do not dismiss the alternatives. Each is useful; Harmonia tests whether a constrained workflow can close the decision gap between information and professional care.
- Proof
- Official sources confirm personalised memberships and AI parenting products already exist; the appendix carries the dated evidence.
- Do not hide
- Differentiation and superior outcomes are not established.
- Likely follow-up
- Expect ‘why not ChatGPT?’—answer with protocols, boundaries, evaluation, and feedback rather than model branding.
Slide 4 One Croatian-speaking cohort. One recurring non-emergency job.
Assumption · Working ICP hypothesis; not validated demand.
- Say
- We start with one Croatian-speaking cohort and one recurring non-emergency challenge so value and safety can be measured.
- Proof
- This scope matches founder access and the frozen commercial-test design.
- Do not hide
- The ICP is a product hypothesis, not proven demand.
- Likely follow-up
- Expect questions about exclusions, qualification, and how the first challenge is chosen.
Slide 5 Context in. One governed action out. Outcome recorded.
Product intent · Target product behaviour; implementation state pending verification.
- Say
- The workflow captures minimum context, selects a governed path, offers one bounded step, and records what happened.
- Proof
- The architecture appendix separates retrieval, generation, deterministic protocols, refusal, and escalation.
- Do not hide
- No shipped workflow or UI is being represented here.
- Likely follow-up
- Expect questions about protocol rights, model choice, logging, deletion, and human review coverage.
Slide 6 Immediate guidance is limited to defined non-emergency situations.
Product intent · Required design boundary; clinical, legal, technical, and privacy evidence pending.
- Say
- Defined non-emergency guidance stops when medical, developmental, abuse, violence, self-harm, safeguarding, or emergency indicators appear.
- Proof
- Child-centred AI and data-protection guidance provide the design baseline; source links are in Q&A.
- Do not hide
- Clinical ownership, thresholds, jurisdiction-specific routes, red-team evidence, and incident operations are not yet complete.
- Likely follow-up
- Expect a diligence request for the escalation map and harmful-output test protocol.
Slide 7 Expand one governed loop into the family support system.
Product intent · Future scope; not seed-period delivery.
- Say
- The full ambition remains a governed family support system: profiles, living plans, progress, professional summaries, education, quality time, broader ages, and multiple children.
- Proof
- The supplied app specification and screening, technique, and UI sources describe these connected capability groups.
- Do not hide
- This is product intent, not simultaneous seed-period delivery. Expansion depends on the first loop passing value, safety, retention, rights, and operating gates.
- Likely follow-up
- Expect questions about sequencing, what evidence unlocks each module, and which capabilities should remain deterministic.
Slide 8 We have problem access. The seed must earn product proof.
Target · Workshops are unverified internal evidence—not app validation.
- Say
- The seed funds a 100-parent, 90-day consented programme: a four-week active protocol with eight-week follow-up.
- Proof
- Targets are 60% activation, 35% week-four retention of activated parents, 15% paid continuation by week six, and zero unhandled high-severity events.
- Do not hide
- These are internal targets, not benchmarks or achieved results. €8.99 and €11.99 are price assumptions.
- Likely follow-up
- Expect denominator, recruitment-quality, adverse-event, comparator, and channel-capacity questions.
Slide 9 The round buys evidence gates—not an eight-year forecast.
Target · No EBITDA year; release gates need accountable approval.
- Say
- The return narrative is a sequence of evidence gates: governance and prototype, pilot, closed alpha, paid beta, then repeat, launch, or stop.
- Proof
- The send-ahead deck assigns the sequence across the 18-month target runway.
- Do not hide
- Owners, detailed dates, and monthly spend remain diligence items.
- Likely follow-up
- Expect a request for kill criteria and what happens if only some gates pass.
Slide 10 Family access, psychology, and commercial execution—with ownership gaps made explicit.
Internal evidence · Commitment, biographies, technical ownership, and governance roles require verification.
- Say
- Sven brings business development, marketing, and programme execution. Tihana brings psychology and family-support experience.
- Proof
- The source deck and integrated content draft state those roles.
- Do not hide
- Commitment, decision rights, biographies, adviser consent, and engineering/security/privacy ownership remain unverified.
- Likely follow-up
- Expect ‘who builds it?’ and ‘who owns clinical and security decisions?’
Slide 11 €400k to fund the proof—not the fantasy.
Assumption · Amount and 18-month runway remain pending a founder-approved monthly cash ledger.
- Say
- The provisional ask is €400k to fund one cohort, one governed workflow, one acquisition loop, and an 18-month evidence decision.
- Proof
- The main and appendix slides use one amount and one runway assumption consistently.
- Do not hide
- No EBITDA date, terms, financing commitment, or automatic follow-on is claimed.
- Likely follow-up
- Invite review of the pilot protocol, architecture, data map, and reconciled monthly driver model.